Scienture’s Insider Buying Surge Signals Confidence Amid GPO Expansion for Naloxone
Scienture Holdings insider buying spurs hope as executive purchases 2.27 m shares, backing GPO deals to expand naloxone REZENOPY® reach and stabilize share price volatility.
4 minutes to read